|
SEC63 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.06499999996679E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.82038999999579E-05 |
| Normal-vs-Stage2 |
5.353800E-04 |
| Normal-vs-Stage3 |
7.71459995885238E-09 |
| Normal-vs-Stage4 |
5.80120000037709E-07 |
| Stage1-vs-Stage2 |
7.105000E-01 |
| Stage1-vs-Stage3 |
1.232150E-02 |
| Stage1-vs-Stage4 |
8.195700E-02 |
| Stage2-vs-Stage3 |
1.915630E-01 |
| Stage2-vs-Stage4 |
2.699200E-01 |
| Stage3-vs-Stage4 |
9.988200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11920000045451E-07 |
| Normal-vs-AfricanAmerican |
2.201800E-02 |
| Normal-vs-Asian |
1.631530E-04 |
| Caucasian-vs-AfricanAmerican |
2.680400E-01 |
| Caucasian-vs-Asian |
5.528800E-01 |
| AfricanAmerican-vs-Asian |
5.504800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.09849999985201E-07 |
| Normal-vs-Female |
1.84655999999617E-05 |
| Male-vs-Female |
1.492190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.159890E-04 |
| Normal-vs-Age(41-60Yrs) |
6.44420000028845E-07 |
| Normal-vs-Age(61-80Yrs) |
1.75660000001354E-06 |
| Normal-vs-Age(81-100Yrs) |
2.782500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.853000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.494200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.556400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.730000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.299800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.113000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.009540E-04 |
| Classical-VS-Follicular |
8.212000E-01 |
| Classical-VS-Other |
3.546200E-01 |
| Classical-VS-Normal |
3.78930000000111E-05 |
| Tall-VS-Follicular |
3.002200E-03 |
| Tall-VS-Other |
4.598600E-01 |
| Tall-VS-Normal |
5.63610047521479E-10 |
| Follicular-VS-Other |
4.798600E-01 |
| Follicular-VS-Normal |
3.033000E-04 |
| Other-VS-Normal |
7.522900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62230000000374E-06 |
| Normal-vs-N1 |
4.09340000007141E-07 |
| N0-vs-N1 |
1.309800E-01 |
|
|
